Dr. Steven DeKosky provides indicators to help “guestimate” rate of cognitive decline.
Conversation article co-authored by Drs. Steven DeKosky and Michael Jaffee discusses new research about dementia and COVID-19 risk.
View a recording of Drs. Todd Golde and Steven DeKosky’s UF Health Webinar.
In The Conversation, Drs. Golde and DeKosky explain the new test, which shows high accuracy in detecting chemicals specific to Alzheimer’s.
In her new role, Dr. Jada Lewis will continue to focus on the MBI's education and outreach activities.
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.
Dr. Steven DeKosky, M.D., was listed among the most influential authors in his field worldwide based on frequency of citations by peers.
Retired Col. Dr. Michael Jaffee and Dr. Steven DeKosky explain military-related risks of developing dementia that are detailed in a new paper in the journal Alzheimer’s & Dementia.
Steven DeKosky, M.D., professor of neurology and deputy director of the McKnight Brain Institute, was recently featured in a story published by the American Academy of Neurology's Brain & Life magazine revisiting the paper he co-authored with Dr. Bennet Omalu about CTE.
Bill Gates recently invested in a venture fund to improve diagnostic testing for Alzheimer's. Steven DeKosky, M.D., discusses the importance of an early diagnosis for patients and researchers.